BruceGGordonMD

PubMed

• 25 citations
  Vulnerability in Research: Basic Ethical Concepts and General Approach to Review.
  Bruce Geoffrey Gordon
  Ochsner Journal. 2020-01-01
• 196 citations
  High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
  Julie M. Vose, James R. Anderson, Anne Kessinger, Philip J. Bierman, Peter F. Coccia
  Journal of Clinical Oncology. 1993-10-01
• 60 citations
  Autologous Hematopoietic Stem-Cell Transplantation for Relapsed or Refractory Hodgkin's Disease in Children and Adolescents
  K. Scott Baker, Bruce Geoffrey Gordon, Thomas G. Gross, Minnie Abromowitch, Elizabeth Lyden
  Journal of Clinical Oncology. 1999-03-01

Journal Articles

• Physician Approaches to Drug Shortages: Results of a National Survey of Pediatric Hematologist/Oncologists  
  Beck JC, Chen B, Gordon BG, World J Clin Oncol, 1/1/2017
• No Girls Allowed: A Sponsor's Rejection of one IRB's Contraception Policy  
  Brown JS, Schonfeld TL, Amoura NJ, Gordon BG, IRB Ethics Hum Res, 1/1/2014
• Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia  
  Patel S, Coulter D, Grovas A, Gordon B, Harper J, Warkentin P, Wisecarver J, Sanger W, Coccia P, J Pediatr Hematol Oncol, 1/1/2014
• A Pregnancy Testing Policy for Women Enrolled in Clinical Trials  
  Schonfeld T, Schmid K, Brown J, Amoura NJ, Gordon B, IRB: Ethics & Human Research, 1/1/2013
• Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours  
  Baheti G, McGuire TR, Davda JP, Manouilov KK, Wall D, Gwilt PR, Gordon B, Xenobiotica, 1/1/2013
• Protecting patient privacy redux: response to open peer commentaries on "'you don't know me, but …': access to patient data and subject recruitment in human subjects r...  
  Schonfeld T, Brown JS, Amoura NJ, Gordon B, Am J Bioeth, 1/1/2012
• "You Don�t Know Me, But�": Ethical access and subject recruitment in human subjects research  
  Schonfeld T, Amoura NJ, Brown J, Gordon B, Amer J Bioethics, 1/1/2011
• Ideal vs Real: Revisiting contraception guidelines  
  Schonfeld T, Brown JS, Amoura NJ, Gordon B, IRB Ethics Hum Res, 1/1/2010
• Women and contraception in research: a pilot study  
  Schonfeld TL, Amoura NJ, Stoner JA, Gordon BG, J Women's Health, 1/1/2009
• Money Matters  
  Schonfeld T, Gordon B, Amoura NJ, Brown J, Am J Bioethics, 1/1/2007
• "You May Have Already Won�": An examination of the use of lottery payments in research  
  Brown JS, Schonfeld TL, Gordon B, IRB: Ethics and Human Res, 1/1/2006
• Management of conflict of interest of IRB members  
  Prentice ED, Mann SL, Paulsen GA, Gordon BG, Med Res Law Policy Rep, 1/1/2005
• Contraception in Research: A Policy Suggestion  
  Gordon B, Schonfeld T, IRB: Ethics and Human Res, 1/1/2005
• Subject Protection and the Risk-Benefit Relationship  
  Schonfeld TL, Brown JS, Gordon B, Am J Bioethics, 1/1/2005
• Evaluation of the process of consent during protocol review  
  Prentice ED, Gordon BG, Mann SL, Kotulak GD, Paulsen GA, Epperson KJ, Med Res Law Policy Rep, 1/1/2004
• Use of an IRB application to enhance review of human subject research  
  Prentice ED, Gordon BG, Mann SL, Kotulak GD, Paulsen GA, Epperson KJ, Med Res Law Policy Rep, 1/1/2004
• Nebraska Medical Center IRB primer on the HIPAA privacy rule  
  Prentice ED, Mann SL, Wrobel S, Gordon BG, Med Res Law Policy Rep, 1/1/2003
• Research involving the homeless: arguments against payment-in-kind  
  Schonfeld T, Brown J, Weniger M, Gordon B, IRB: Ethics and Human Res, 1/1/2003
• Analysis and Perspective: The institutional review board�s adverse event report dilemma  
  Prentice ED, Oki G, Gordon BG, Zaia JA, Med Res Law Policy Rep, 1/1/2002
• Full hematopoietic engraftment after allogeneic bone marrow transplantation in a child with severe combined immunodeficiency  
  Rubocki RJ, Parsa JR, Hershfield MS, Sanger WG, Pirrucello SJ, Santisteban I, Gordon BG, Strandjord SE, Warkentin PI, Coccia PF, Blood, 1/1/2001
• Human subjects protection in the United States: a short history  
  Gordon BG, Prentice ED, J Pub Health Manage Practice, 1/1/2000
• Case Study: Conflict Between Research Design and Minimization of Risks in Pediatric Research  
  Gordon BG, Prentice ED, Anderson JR, IRB: Rev Human Subjects Res, 1/1/2000
• Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients  
  Gordon B, Lyden E, Lynch J, Tarantolo S, Pavletic ZS, Bishop M, Reed E, Kessinger A, Haire W, Bone Marrow Transpl, 1/1/2000
• Selective review of external adverse events: one IRB=s response to the avalanche of IND safety reports  
  Gordon B, Prentice E, IRB: Rev Human Subjects Res, 1/1/1999
• Post-transplant Epstein-Barr virus associated meningoencephalitis and lymphoid interstitial pneumonitis  
  Davis KR, Hinrichs SH, Fidler JL, Henry TJ, Davis JR, Baker KS, Gordon BG, Gross TG, Bone Marrow Transpl, 1/1/1999
• Join now to see all

Books/Book Chapters

• Bioemergency Planning: A Guide for Healthcare Facilities 
  Chapter: Human Subjects Research in Bioemergencies. 
  Sauer LM, Evans JD, Shaw-Saliba K, Gordon BG, Kratochvil CEditors: Hewlett A, Murthy R.Springer International Publishing AG, Cham, Switzerland2018
• Institutional Review Board. Management and Function 
  Chapter: Requiring Birth Control to Participate in Research. 
  Gordon B, Schonfeld T, Prentice EEditors: Amdur R, Bankert E.Jones and Bartlett Publishers, Sudbury, MA2006
• Institutional Review Board. Management and Function 
  Chapter: Paying Research Subjects. 
  Gordon B, Brown J, Kratochvil C, Schonfeld T, Prentice EEditors: Amdur R, Bankert E.Jones and Bartlett Publishers, Sudbury, MA2006
• Institutional Review Board. Management and Function 
  Chapter: Regulatory Issues of Research Involving Prisoners. 
  Kratochvil C, Prentice E, Gordon B, Kotulak GEditors: Amdur R, Bankert E.Jones and Bartlett Publishers, Sudbury, MA2006
• Institutional Review Board. Management and Function 
  Chapter: IRB Review of Adverse Events. 
  Kratochvil C, Prentice E, Epperson K, Gordon BEditors: Amdur R, Bankert E.Jones and Bartlett Publishers, Sudbury, MA2006
• Institutional Review Board. Management and Function 
  Chapter: Administrative Reporting Structure for the IRB. 
  Prentice E, Mann S, Gordon BEditors: Amdur R, Bankert E.Jones and Bartlett Publishers, Sudbury, MA2006
• Institutional Review Board. Management and Function 
  Chapter: Charging for IRB Review. 
  Prentice E, Mann S, Gordon BEditors: Amdur R, Bankert E.Jones and Bartlett Publishers, Sudbury, MA2006
• Pediatric Hematopoietic Stem Cell Transplantation. 
  Chapter: Hematopoietic Stem Cell Transplantation for Children with Hodgkin and Non-Hodgkin Lymphoma. 
  Gordon B, Baker KSEditors: Klein R.Taylor and Francis Publishers, New York, NY2006
• Public Health Administration: Organization and Strategy for Population Based Management. 
  Chapter: Public Health Agency Approaches to Human Subjects Research Review. 
  MacCubbin PA, Gordon B, Prentice EEditors: L Novick.Aspen Publishers, Gaithersburg, MD2001
• High-Dose Cancer Therapy. Pharmacology, Hematopoietins, Stem Cells 
  Chapter: High Dose Therapy and Stem Cell Transplantation for Neuroblastoma and Other Pediatric Solid Tumors. 
  Gordon B, Coccia PEditors: JO Armitage, KH Antman.Lippincott Williams & Wilkins, Baltimore, MD2000
• Adolescent Nutrition: Assessment and Management. 
  Chapter: Nutritional Aspects of Organ Transplantation. 
  Antonsen DL, Houser MT, Gordon BG, Guest JE, Walter GA, Mack DREditors: VI Rickert.Chapman & Hall, New York1996
• Patient Oriented Problem Solving (POPS) System in Pharmacology 
  Chapter: Cancer Chemotherapy. 
  Scholar EM, Kawahara RS, Gordon BG1993
• Join now to see all

Abstracts/Posters

• The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact.
  Anderson B, Goldberg J, Adler J, Covington L, Olson D, Sowale Y, Gordon B, Reaman G, Everett J, Krailo M, Smith M, Christian M, Proc Amer Soc Clin Oncol, 1/1/2007
• High dose chemotherapy with stem cell rescue for children with relapsed and high risk solid tumors; preliminary survival analyses: ONC9616, A Pediatric Blood and Marro...
  Gamis A, Wall D, Gordon B, Watanabe M, Laurence K, Simon S, Blood, 1/1/2001
• Trends in pediatric autologous transplantation 1995-1999: a study of the Pediatric Blood and Marrow Transplant Consortium.
  Joyce M, Harvey A, Wall D, Gordon B, Gamis A, Sandler E, J Pediatr Hematol Oncol, 1/1/2001
• Normal children as allogeneic peripheral blood stem cell (allo PSC) donors: ethical considerations.
  Gordon B, Anderson J, Gilmore S, Combined meeting of the Pediatric Academic Societies and the American Society of Pediatric Hematology /Oncology; J Pediatr Hematol Oncol, Baltimore, MD, 1/1/2001
• Population pharmacokinetics of etoposide and thiotepa in children undergoing high dose chemotherapy (for the Pediatric Blood and Marrow Transplant Consortium).
  Gwilt P, McGuire T, Wall D, Shenoy S, Manouilov K, Cheruku S, Gordon B, Blood, 1/1/2000
• Protecting children and minors in biomedical research.
  Gordon B, Fleisher M, Meeting of the International Association for the Scientific Study of Intellectual Disabilities; J Intellectual Disability Res, Seattle, WA, 1/1/2000
• Ethical issues in human biomedical research.
  Fleisher M, Prentice E, Gordon B, Kratochvil C, J Intellectual Disability Res, 1/1/2000
• Diagnostic accuracy and clinical relevance of the subclassification of small noncleaved cell lymphoma.
  Chai C, Auon P, Greiner T, Lynch J, Bishop J, Chan W, Gordon B, Armitage J, Weisenburger D, Mod Pathol, 1/1/2000
• Clusterin expression is associated with anaplastic large cell lymphoma (ALCL) of T/Null cell phenotype with ALK expression.
  Aoun P, Greiner T, Lynch J, Vose J, Gordon B, Chan W, Weisenburger D, Modern Pathology, 1/1/2000
• Prognostic significance of cytotoxic T-cell intracellular antigen 1 (TIA-1) and granzyme B (BG-B) in peripheral T-cell lymphoma (PTCL).
  Aoun P, Greiner T, Vose J, Kollath J, Morris S, Gordon B, Chan W, Weisenburger D, Mod Pathol, 1/1/1999
• bcl2 and p53 gene expression predict survival in the small noncleaved cell lymphomas.
  Chai C, Auon P, Greiner T, Bishop J, Lynch J, Chan W, Bierman P, Gordon B, Vose J, Armitage J, Weisenburger D, Mod Pathol, 1/1/1999
• Diffusing capacity (DLCO) and exercise-induced hypoxemia in children undergoing bone marrow transplantation (BMT).
  Colombo JL, Mommsen JJ, Gordon BG, Hallberg TK, Judy CG, Sammut PH, Am J Resp Dis Critical Care Med, 1/1/1999
• Correlation of International Scoring System for myelodysplastic syndrome with outcome following allogeneic stem cell transplantation.
  Bishop MR, Lynch JC, Aoun P, Gordon BG, Tarantolo S, Pavletic ZS, Morris ME, Sannoufi S, Coccia PF, Armitage JO, Kessinger A, Proc Amer Soc Clin Oncol, 1/1/1999
• Concurrent factor V Leiden and dysplasminogenemia presenting as venous thrombosis in a child with mediastinal germ cell tumor.
  Christianson H, Gordon B, Haire W, J Pediatr Hematol Oncol, 1/1/1999
• Trends in pediatric transplantation 1994 - 1997: a study of the Pediatric Blood and Marrow Transplant Consortium (PBMTC).
  Sandler E, Harvey A, Remmer R, Wall D, Gordon B, J Pediatr Hematol Oncol, 1/1/1999
• Changing patterns of supportive care among pediatric stem cell transplantation (SCT) centers in North America.
  Aquino VM, Farah RA, Gordon B, Chan KW, Wall D, Sandler ES for the Pediatric Blood and Marrow Transplant Consortium, J Pediatr Hematol Oncol, 1/1/1999
• Cytogenetic abnormalities in tumors from children with non Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD): Nebraska Lymphoma Study Group experience.
  Gordon B, Sanger W, Weisenburger D, Bast M, Pickering D, Hess M, Bierman P, Vose J, Harper J, Abromowitch M, Armitage J, Coccia P, Meeting of the American Society of Pediatric Hematology Oncology; J Pediatr Hematol Oncol, 1/1/1999
• Indolent non-Hodgkin's lymphoma (NHL) in children and young adults: a clinicopathologic study of 19 cases.
  Gordon B, Weisenburger D, Lynch J, Bast M, Bierman P, Vose J, Bociek G, Armitage J, Meeting of the American Society of Hematology; Blood, 1/1/1999
• Anaplastic lymphoma kinase (ALK): an important predictor of survival in peripheral T cell lymphoma.
  Aoun P, Greiner T, Vose J, Gordon B, Kollath J, Morris S, Chan W, Weisenburger D, Mod Pathol, 1/1/1998
• Brain magnetic resonance spectroscopy (MRS) before and after bone marrow transplantation (BMT).
  McConnell JR, Gordon BG, Coccia PF, Gross TG, Schaefer GB, 5th International Conference on the Long-Term Complications of Treatment of Children and Adolescents for Cancer, 1/1/1998
• Hematopoietic stem cell transplantation (HSCT) for children with non-Hodgkin's lymphoma (NHL): a multi-institutional analysis from the Pediatric Blood and Marrow Trans...
  Gordon B for the Pediatric Blood and Marrow Transplant Consortium, Marrow Transplantation in Children: Current Results and Controversies, 1/1/1998
• Hematopoietic stem cell transplantation (HSCT) for relapsed Ki-1 positive T cell non-Hodgkin lymphoma (NHL) in children: long term follow-up of patients prepared with ...
  Gordon B, Weisenburger D, Harper J, Baker K, Gross T, Abromowitch M, Warkentin P, Coccia P, Meeting of the American Society of Pediatric Hematology/Oncology; J Pediatr Hematol Oncol, 1/1/1998
• Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients.
  Gordon B, Ruby E, Lynch J, Stephens L, Kessinger A, Haire W, Meeting of the American Society of Hematology; Blood, 1/1/1998
• Is the survival of patients with peripheral T cell lymphoma (PTCL) different from patients with diffuse aggressive B cell lymphoma?
  Aoun P, Greiner T, Vose J, Gordon B, Kollath J, Bast M, Morris S, Chan W, Bierman P, Armitage J, Weisenburger D, Blood, 1/1/1998
• Cytokine analysis of stem cell transplant patients with multiple organ dysfunction syndrome (MODS).
  Baker KS, Gordon BG, Gross TG, Stucky T, Stephens LC, Ruby EI, Kessinger A, Haire WD, Blood, 1/1/1997
• Join now to see all

Lectures

• "Research Ethics" 
  2010-2016 - 1/1/2017
• IRB Education Series (various topics) 
  2012-2016 - 1/1/2017
• "Regulatory framework for multicenter trials: Single IRB review" 
  1/1/2017
• "Single IRB Review of Multi-Center Clinical Trials" 
  1/1/2017
• "Ethical and practical issues in conducting research on Ebola and other emerging pathogens" 
  1/1/2016
• "IRB Chair Forum" 
  1/1/2016
• "It's not just about the genes: Managing radiographic incidental findings" 
  1/1/2016
• Vulnerable Subjects 
  1/1/2016
• IRB Chair Boot Camp 
  2014 - 1/1/2016
• "It's not just about the genes: Managing radiographic incidental findings" 
  1/1/2016
• "From West Africa to Omaha: Research on Ebola and Other Emerging Pathogens" Web Conference 
  1/1/2016
• "Ethical Issues in Subject Recruitment" 
  1/1/2015
• "Case Studies in Pediatric Research: Working through Subpart D" 
  1/1/2015
• "From West Africa to Omaha: Research on Ebola and Other Emerging Pathogens" 
  1/1/2015
• "Who are vulnerable subjects? And how should they be protected?" 
  Singapore - 1/1/2014
• "Special Ethical and Practical Issues Related to Research Involving Adolescents" 
  1/1/2014
• Characteristics of IRB Chairs Among US IRBs 
  1/1/2014
• "Exempt or Expedited? How to Tell the Difference" 
  1/1/2014
• "Ethics and Regulation of Human Subjects Research" 
  1/1/2014
• "Consent: How Informed and How to Inform?" 
  1/1/2014
• "Introduction to the Psychologic Dynamics of an IRB Meeting" 
  1/1/2013
• "Human Subjects Research and the IRB" 
  2002-2011 - 1/1/2012
• "Research with Biobanks: Ethics, Regulation and Policy Issues" 
  Shanghai, PRC - 1/1/2012
• "Children in Research: They're Not Just Small Adults" 
  1/1/2012
• "Children as Research Subjects: They�re Not Just Small Adults" 
  New York University School of Medicine - 1/1/2012
• Join now to see all

Other

• Institutional Review Board assessment of risk and benefits associated with research. 
  Prentice ED, Gordon BG, Commissioned paper for the National Bioethics Advisory Committee
  http://onlineethics.org/reseth/nbac/hprentice.html